AC Immune S.A.
ACIU | NASDAQ
$2.65
+$0.02 (+0.76%)
At close: Sep 21, 2026, 4:00 PM ET
$2.65
$0 (+0.19%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $270.21M
Enterprise Value $147.16M
Beta 1.60
Average Volume 256.48K
Shares Outstanding (Diluted) 98.67M
Shares Change YoY -1.95%
Institutional Ownership 25.42%
Exchange NASDAQ
ISIN CH0329023102
Price Performance
Price Change 1M -8.9%
Price Change 3M 8.2%
Price Change 6M -9.9%
Price Change YTD -21.1%
Price Change 1Y 4.7%
Price Change 3Y -10.8%
Price Change 5Y -61.6%
1M CAGR (ann.) 12.7%
1Y CAGR (ann.) 5.6%
5Y CAGR (ann.) -17.5%
All-Time CAGR -16.3%
Valuation
PE Ratio -4.89
Forward PE 10.25
PEG Ratio 0.25
Forward PEG 0.03
PS Ratio 12.24
Forward PS 2.50
PB Ratio 6.21
P/FCF Ratio -6.13
P/Adj. FCF Ratio -5.70
P/OCF Ratio -6.00
EV/Sales 8.40
EV/EBIT -3.42
EV/EBITDA -3.50
EV/FCF -4.21
Earnings Yield -19.7%
FCF Yield -15.7%
Adj. FCF Yield -16.9%
Financial Health
Net Cash CHF75.36M
Total Debt CHF4.1M
Cash & Short-Term Investments CHF75.36M
Total Assets CHF150.4M
Current Ratio 0.93
Quick Ratio 0.93
Debt / Equity Ratio 0.12
Debt / EBITDA -0.10
Debt / FCF -0.12
OCF / Debt -8.48
Interest Coverage -263.40
Altman Z-Score -3.94
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 100.0%
Operating Profit Margin -252.3%
EBITDA Margin -239.8%
Net Profit Margin -246.5%
FCF Margin -199.6%
Adj. FCF Margin -214.6%
SBC / Revenue 15.0%
SBC Impact (per share) -7.5%
Returns
Return on Assets -28.7%
Return on Equity -99.2%
Return on Invested Capital -86.6%
Return on Capital Employed -88.0%
Return on Tangible Assets -43.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 64.5%
Revenue CAGR 5Y 53.3%
Revenue CAGR 10Y -9.0%
EPS CAGR 3Y 20.9%
EPS CAGR 5Y 20.8%
EPS CAGR 10Y -4.3%
FCF CAGR 3Y -339.7%
FCF CAGR 5Y 29.6%
FCF CAGR 10Y -6.4%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 9
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y 62.3%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) -$0.27
EPS Growth Est (next Q) 10.0%
Revenue Est (next Q) $295.22K
Revenue Growth Est (next Q) -79.4%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $8.33
Price Target Upside 214.3%
Cash Flow
Operating Cash Flow CHF-34.79M
Free Cash Flow CHF-34.95M
Adj. Free Cash Flow CHF-37.58M
FCF Per Share -$0.35
OCF Per Share -$0.35
OCF/S Ratio -198.7%
Income Statement
Revenue CHF17.51M
Gross Profit CHF17.51M
Operating Income CHF-44.17M
EBITDA CHF-42M
Net Income CHF-43.16M
EPS (Diluted) -$0.43
Revenue / Employee $165.18K
Profit / Employee $-407.15K
Employees 106
Add to Watchlist
Select watchlists to add or remove ACIU